A. Marriott

发表

Eosinophil-Mediated Immune Control of Adult Filarial Nematode Infection Can Proceed in the Absence of IL-4 Receptor Signaling

J. Archer, A. Steven, Mark J. Taylor, 2020, The Journal of Immunology.

Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?

S. Ward, Paul M O' Neill, Mark J. Taylor, 2020, Veterinary parasitology.

Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models

J. Archer, A. Steven, Mark J. Taylor, 2018, Scientific Reports.

A mouse infection model and long-term lymphatic endothelium co-culture system to evaluate drugs against adult Brugia malayi

J. Archer, A. Steven, J. Turner, 2022, PLoS neglected tropical diseases.

Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor–mediated lymphangiogenesis

J. Archer, M. Mack, A. Steven, 2021, The Journal of clinical investigation.

NKp46+ natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infection

J. Archer, A. Steven, S. Wanji, 2022, Frontiers in Immunology.

Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19

Jordan J. Clark, J. Stewart, D. Matthews, 2020, bioRxiv.

Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: Trichuris muris, Brugia malayi, Heligmosomoides polygyrus, and Schistosoma mansoni

G. Wynne, J. Keiser, J. Archer, 2021, ACS infectious diseases.

Structural requirements for dihydrobenzoxazepinone anthelmintics: actions against medically important and model parasites - Trichuris muris, Brugia malayi and Heligmosomoides polygyrus

J. Keiser, J. Archer, D. Sattelle, 2020, bioRxiv.

Wolbachia depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment

J. Archer, J. Hemingway, A. Steven, 2022, Proceedings of the National Academy of Sciences of the United States of America.

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

J. Kool, R. Harrison, N. Casewell, 2022, Toxicon: X.

A dirofilariasis mouse model for heartworm preclinical research

P. Selzer, C. Wilson, F. Gusovsky, 2023, bioRxiv.

Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis

A. Steven, Alexandra Ehrens, M. Hübner, 2024, Frontiers in microbiology.

Molecular dissection of cobra venom highlights heparinoids as an antidote for spitting cobra envenoming

Christopher E. Denes, Laura-Oana Albulescu, N. Casewell, 2024, Science Translational Medicine.